Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

Author： Liu Jianhua   Tu Dongsheng   Dancey Janet   Reyno Leonard   Pritchard Kathleen I.   Pater Joseph   Seymour Lesley K  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.100, Iss.3, 2006-12, pp. : 263-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 49-51

Informa Healthcare

Access to resources Recommend Favorite

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

By Amadori D.   Frassineti G.L.   de Matteis A.   Mustacchi G.   Santoro A.   Cariello S.   Ferrari M.   Nascimben O.   Nanni O.   Lombardi A.   Scarpi E.   Zoli W.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 209-217

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer

By Campos Susana   Berlin Suzanne   Parker Leroy   Chen Wendy   Bunnell Craig   Atkinson Tina   Lee Julie   Matulonis Ursula   Hirsch Michelle   Harris Lyndsay   Krasner Carolyn  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 390-398

Springer Publishing Company

Access to resources Recommend Favorite